---
figid: PMC3221408__fneur-02-00068-g001
figlink: /pmc/articles/PMC3221408/figure/F1/
number: Figure 1
caption: The mechanisms of action of neuroprotective agents that are in clinical trials.
  Rasagiline shows neuroprotective properties by suppressing mitochondrial apoptosis
  stopping the mitochondrial permeability transition pore (MPT) opening by inhibiting
  caspase-3, nuclear poly [ADP-ribose] polymerase 1 (PARP-1) activation, stopping
  the translocation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and halting
  nucleosomal DNA fragmentation. Rasagiline increases the expression of the anti-apoptotic
  proteins B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma-extra large (Bcl-xL) through
  the protein kinase C (PKC) pathway, in addition to down-regulating the pro-apoptotic
  Bcl-2-associated death promoter (Bad) and Bcl-2-associated X protein (Bax). Minocycline
  inhibits the inflammatory response to prevent cell death and it chealates metals.
  Creatine inhibits activation of the MPT and represses iron (Fe2+) accumulation.
pmcid: PMC3221408
papertitle: The Promise of Neuroprotective Agents in Parkinsonâ€™s Disease.
reftext: Stacey E. Seidl, et al. Front Neurol. 2011;2:68.
pmc_ranked_result_index: '69996'
pathway_score: 0.9771565
filename: fneur-02-00068-g001.jpg
figtitle: Mechanisms of action of neuroprotective agents that are in clinical trials
year: '2011'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3221408__fneur-02-00068-g001.html
  '@type': Dataset
  description: The mechanisms of action of neuroprotective agents that are in clinical
    trials. Rasagiline shows neuroprotective properties by suppressing mitochondrial
    apoptosis stopping the mitochondrial permeability transition pore (MPT) opening
    by inhibiting caspase-3, nuclear poly [ADP-ribose] polymerase 1 (PARP-1) activation,
    stopping the translocation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
    and halting nucleosomal DNA fragmentation. Rasagiline increases the expression
    of the anti-apoptotic proteins B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma-extra
    large (Bcl-xL) through the protein kinase C (PKC) pathway, in addition to down-regulating
    the pro-apoptotic Bcl-2-associated death promoter (Bad) and Bcl-2-associated X
    protein (Bax). Minocycline inhibits the inflammatory response to prevent cell
    death and it chealates metals. Creatine inhibits activation of the MPT and represses
    iron (Fe2+) accumulation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP12
  - PRKCZ
  - PRKCB
  - PRKD3
  - CASP1
  - BCL2L1
  - CASP14
  - PRKCA
  - GAPDH
  - CASP9
  - PRKCE
  - PARP1
  - PRKCD
  - CASP8
  - PRKCQ
  - CASP2
  - CASP10
  - CASP5
  - PRKCG
  - PRKCH
  - CASP6
  - PRKCI
  - BCL2
  - CASP7
  - CASP3
  - CASP4
  - Rasagiline
  - Creatine
  - Minocycline
genes:
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Bcl-XL
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: GAPDH
  symbol: GAPDH
  source: hgnc_symbol
  hgnc_symbol: GAPDH
  entrez: '2597'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PARP1
  symbol: PARP1
  source: hgnc_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
chemicals:
- word: Rasagiline
  source: MESH
  identifier: C031967
- word: Creatine
  source: MESH
  identifier: D003401
- word: Minocycline
  source: MESH
  identifier: D008911
diseases: []
---
